References
- Donato ML, Aleman A, Champlin RE, et al. High-dose topotecan, melphalan and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of multiple myeloma. Leuk Lymphoma 2004; 45 (4): 755–759.
- Chen B, Ahmed T, Mannancheril A, Gruber M, Benzil DL. Safety and efficacy of high-dose chemotherapy with autologous stem cell transplantation for patients with malignant astrocytomas. Cancer 2004; 100 (10): 2201–2207.
- Auerbach R, Huang H, Lu L, et al. Hematopoietic stem cells in the mouse embryonic yolk sac. Stem Cells 1996; 14: 269–280.
- Choi K, Kennedy M, Kazarov A, et al. A common pre-cursor for hematopoietic and endothelial cells. Development 1998; 125: 725–732.
- Palacios R, Golunski E, Samaridis J, et al. In vitro gen-eration of hematopoietic stem cells from an embryonic stem cell line. Proc Natl Acad Sci USA 1995; 92: 7530–7534.
- Suzuki A, Nakano T. Development of hematopoietic cells from embryonic stem cells. Int J Hematol 2001; 73 (1): 1–5.
- Mukouyama Y, Hara T, Xu M, et al. In vitro expansion of murine multipotential hematopoietic progenitors from the embryonic aorta-gonad-mesonephros region. Immunity 1998; 8 (1): 105–114.
- Carmeliet P, Ferreira V, Breier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380 (6573): 435–439.
- Ferrara N, Carver-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactiva-tion of the VEGF gene. Nature 1996; 380 (6573): 439–442.
- Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of blood-island formation and vasculogenesis in Flk-l-deficient mice. Nature 1995; 376 (6535): 62–66.
- Nakayama N, Fang I, Elliott G et al. Natural killer and B-lymphoid potential in CD34+ cells derived from embryonic stem cells differentiated in the presence of vascular endothelial growth factor. Blood 1998; 91 (7): 2283-2295.
- Nakayama N, Lee J, Chiu L, et al. Vascular endothelial growth factor synergistically enhances bone morphogenetic protein-4-dependent lymphohematopoietic stem cell genera-tion from embryonic stem cells in vitro. Blood 2000; 95 (7): 2275–2283.
- Shizuru JA, Jerabek L, Edwards CT, Weissman IL. Transplantation of purified hematopoietic stem cells: require-ments for overcoming the barriers of allogeneic engraftment. Biol Blood Marrow Transplant 1996; 2 (1): 3–14.
- Wang - B, El-Badri NS, Cherry R, Good A. Purified hematopoietic stem cells without facilitating cells can repopu-late fully allogeneic recipients across entire major histocompat-ibility complex transplantation barrier in mice. Proc Natl Acad Sci USA 1997; 94: 14632–14636.
- Kaufman DS, Hanson ET, Lewis RL, Auerbach R, Thomson JA. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 2001; 98 (19): 10716–10721.
- Palis J, Chan R J, Koniski A, et al. Spatial and tempo-ral emergence of high proliferative potential hematopoietic precursors during murine embryogenesis. Proc Natl Acad Sci USA 2001; 98: 4528–4533.
- Osawa M, Hanada K, Hamada H, Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996; 273 (5272): 242–245.
- Muller AM, Dzierzak EA. ES cells have only a limited lymphopoietic potential after adoptive transfer into mouse recipients. Development 1993; 118 (4): 1343–51.